Regenerative Medicine: Next Generation Treatments

Wednesday, February 8, 2017 — 9:30 a.m. - 11:30 a.m.

Full conference registration is required to attend this session.

Session Chairs:

G. Sitta Sittampalam, Ph.D.
Senior Advisor to the Director, Immediate Office of the Director
National Center for Advancing Translational Sciences
National Institutes of Health

Marcie Glicksman Ph.D.
Chief Scientific Officer

Regenerative medicine is having a big impact on the future of medicine. It has the potential to fully repair damaged cells, tissues and organs. Developments in stem cell technology, tissue engineering and molecular biology are pushing the frontiers of medicine by providing the possibility of cures through the use of cellular therapies. The next decade will see the rapid development of treatments that will employ human iPS cells, drugs and biologics as substrates for therapies in acute and chronic diseases. In this session, presentations will represent the recent advances in the generation, standardization, characterization and the mechanistic behavior of stem cells and their applications in regenerative medicine.

Presentations include: